Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2014 12:47 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces Initiation of Dosing for AEM-28 Phase 1b/2a Human Clinical Trial in Refractory Hypercholesterolemic Subjects

TEMPE, Ariz., June 11, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) ("the Company") and its joint venture affiliate, LipimetiX Development, LLC ("JV"), announced today the initiation of...
May 16, 2014 13:00 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces Operating Update Conference Call

TEMPE, Ariz., May 16, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Wednesday, May 21, 2014 at 4:30 pm EDT. The call may be...
April 08, 2014 09:00 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces Initiation of Dosing for AEM-28 Phase 1 Human Clinical Trial in LDL/non-HDL Cholesterol Reduction

TEMPE, Ariz., April 8, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) ("the Company") and its joint venture affiliate, LipimetiX Development, LLC ("JV"), announced today the initiation of...
March 27, 2014 09:00 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces Operating Update Conference Call, Planned Initiation of AEM-28 Phase 1 Study and Fiscal Year 2013 Financial Results

TEMPE, Ariz., March 27, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) ("the Company") and its joint venture affiliate, LipimetiX Development, LLC ("JV"), today will hold a conference...
March 24, 2014 14:29 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces Operating Update Conference Call

TEMPE, Ariz., March 24, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Thursday, March 27, 2014 at 4:30 pm EDT. The call may...
November 19, 2013 11:00 ET | Source: Capstone Therapeutics

Capstone Therapeutics Announces a LipimetiX Development, LLC Presentation at the American Heart Association Scientific Sessions: Pre-Clinical Data Demonstrating Significant Post Treatment Benefit of AEM-28 on Established Atherosclerotic Lesions

TEMPE, Ariz. and BOSTON, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics' (OTCQB:CAPS) joint venture, LipimetiX Development, LLC, today announced the presentation of pre-clinical data...
November 12, 2013 15:47 ET | Source: Capstone Therapeutics

Capstone Therapeutics to Hold Quarterly Operating Update Conference Call

TEMPE, Ariz., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Thursday, November 21, 2013 at 4:30 pm EST. The call may...
August 14, 2013 08:30 ET | Source: Capstone Therapeutics

Capstone Therapeutics Will Provide an Operating Update and Announces Second Quarter 2013 Financial Results

TEMPE, Ariz., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) (the "Company"), today will hold a conference call and webcast to provide an operating update and announced financial...
August 07, 2013 14:16 ET | Source: Capstone Therapeutics

Capstone Therapeutics to Hold Quarterly Operating Update Conference Call

TEMPE, Ariz., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Wednesday, August 14, 2013 at 4:30 pm EDT. The call may...
May 15, 2013 09:30 ET | Source: Capstone Therapeutics

Capstone Therapeutics Will Provide an Operating Update and Announces First Quarter 2013 Financial Results

TEMPE, Ariz., May 15, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), today will hold a conference call and webcast to provide an operating update and announced financial...